Garrett Motion Inc.
$6.48B- Market cap
- $5.24B
- Debt
- +$1.42B
- Cash
- −$177.00M
Capital structure 79% equity / 21% debt · EV / Revenue 1.81x · EV / EBITDA 11.06x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: GTX stock price at discount vs HIMS $27.99 current versus $82.62 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HIMS's multiple
Implied fair value · at GTX's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GTX FY 2025 (ended Dec 31, 2025) · HIMS FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 79% equity / 21% debt · EV / Revenue 1.81x · EV / EBITDA 11.06x
Capital structure 0% equity / 100% debt · EV / Revenue 0.47x · EV / EBITDA 7.55x
GTX carries the larger enterprise value at $6.48B against $1.11B; HIMS trades on the lower EV / Revenue multiple (0.47x vs 1.81x); HIMS on the lower EV / EBITDA (7.55x vs 11.06x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Garrett Motion Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
HIMS & HERS HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-1.77x
2.48x
Net debt / EBITDA
Leverage against operating earnings
2.12x
7.55x
Cash and equivalents
Liquid reserves on the balance sheet
$177.00M
$228.62M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BORGWARNER INC
GTX vs BWA
AUTOLIV INC
GTX vs ALV
DANA INC
GTX vs DAN
MODINE MANUFACTURING CO
GTX vs MOD
AMERICAN AXLE & MANUFACTURING HOLDINGS INC
GTX vs AXL
LEAR CORP
GTX vs LEA
Teladoc Health, Inc.
GTX vs TDOC
GoodRx Holdings, Inc.
GTX vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
GTX vs CLOV
Roivant Sciences Ltd.
GTX vs ROIV
$1.42B
$1.34B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.